Literature DB >> 15140228

Tandem BRAF mutations in primary invasive melanomas.

Nancy E Thomas1, Audrey Alexander, Sharon N Edmiston, Eloise Parrish, Robert C Millikan, Marianne Berwick, Pamela Groben, David W Ollila, Dianne Mattingly, Kathleen Conway.   

Abstract

The RAS/RAF/MAPK pathway likely mediates critical cell proliferation and survival signals in melanoma. BRAF mutations have been found in a high percentage of melanoma cell lines and metastases; however, only a few studies with a limited number of specimens have focused on primary melanomas. We examined BRAF exon 15 mutational status in 37 primary invasive melanomas of varying thicknesses, which had undergone a standardized pathology review. BRAF mutational status was determined using direct manual sequencing of PCR products, followed by resequencing separately amplified DNA aliquots to confirm each mutation. BRAF exon 15 mutations were found in 17 of 37 (46%) primary melanomas. Tumor-specific tandem mutations, encoding either V599K, V599R, or V599E, were found in 5 of 17 (29%) melanomas with BRAF exon 15 mutations. Cloning of BRAF double base-pair substitutions confirmed that both base changes were on the same allele and can result in a positive charge at codon 599. BRAF mutations, including tandem mutations, were frequently found in both thin and thick primary melanomas, implying that these mutations can occur early in the progression of melanoma. The finding of tandem mutations in thin melanomas makes it more likely that they arise as a simultaneous rather than sequential event.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140228     DOI: 10.1111/j.0022-202X.2004.22523.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

Review 1.  How sunlight causes melanoma.

Authors:  Lilit Garibyan; David E Fisher
Journal:  Curr Oncol Rep       Date:  2010-09       Impact factor: 5.075

2.  Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis.

Authors:  Nancy E Thomas; Sharon N Edmiston; Yihsuan S Tsai; Joel S Parker; Paul B Googe; Klaus J Busam; Glynis A Scott; Daniel C Zedek; Eloise A Parrish; Honglin Hao; Nathaniel A Slater; Michelle V Pearlstein; Jill S Frank; Pei Fen Kuan; David W Ollila; Kathleen Conway
Journal:  Am J Dermatopathol       Date:  2019-04       Impact factor: 1.533

3.  Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Peter A Kanetsky; Klaus J Busam; Anne Kricker; Bruce K Armstrong; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Li Luo; Irene Orlow; Anne S Reiner; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; Eloise A Parrish; Honglin Hao; David C Gibbs; Jill S Frank; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2017-08-24       Impact factor: 8.551

4.  Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Audrey Alexander; Pamela A Groben; Eloise Parrish; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Lynn From; Klaus J Busam; Honglin Hao; Irene Orlow; Peter A Kanetsky; Li Luo; Anne S Reiner; Susan Paine; Jill S Frank; Jennifer I Bramson; Lorraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  JAMA Oncol       Date:  2015-06       Impact factor: 31.777

5.  DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.

Authors:  Nancy E Thomas; Nathaniel A Slater; Sharon N Edmiston; Xin Zhou; Pei-Fen Kuan; Pamela A Groben; Craig C Carson; Honglin Hao; Eloise Parrish; Stergios J Moschos; Marianne Berwick; David W Ollila; Kathleen Conway
Journal:  Pigment Cell Melanoma Res       Date:  2014-07-14       Impact factor: 4.693

6.  Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.

Authors:  Kathleen Conway; Sharon N Edmiston; Joel S Parker; Pei Fen Kuan; Yi-Hsuan Tsai; Pamela A Groben; Daniel C Zedek; Glynis A Scott; Eloise A Parrish; Honglin Hao; Michelle V Pearlstein; Jill S Frank; Craig C Carson; Matthew D Wilkerson; Xiaobei Zhao; Nathaniel A Slater; Stergios J Moschos; David W Ollila; Nancy E Thomas
Journal:  J Invest Dermatol       Date:  2018-12-06       Impact factor: 8.551

7.  Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma.

Authors:  Molly Yancovitz; Joanne Yoon; Maryann Mikhail; Weiming Gai; Richard L Shapiro; Russell S Berman; Anna C Pavlick; Paul B Chapman; Iman Osman; David Polsky
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

8.  Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site.

Authors:  Anton Platz; Suzanne Egyhazi; Ulrik Ringborg; Johan Hansson
Journal:  Mol Oncol       Date:  2007-12-28       Impact factor: 6.603

9.  Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.

Authors:  William K Kaufmann; Kathleen R Nevis; Pingping Qu; Joseph G Ibrahim; Tong Zhou; Yingchun Zhou; Dennis A Simpson; Jennifer Helms-Deaton; Marila Cordeiro-Stone; Dominic T Moore; Nancy E Thomas; Honglin Hao; Zhi Liu; Janiel M Shields; Glynis A Scott; Norman E Sharpless
Journal:  J Invest Dermatol       Date:  2007-06-28       Impact factor: 8.551

Review 10.  The Role of Senescent Cells in Acquired Drug Resistance and Secondary Cancer in BRAFi-Treated Melanoma.

Authors:  Elizabeth L Thompson; Jiayi J Hu; Laura J Niedernhofer
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.